Heilpflanzen-Welt - Die Welt der Heilpflanzen!
Heilpflanzen-Welt - Natürlich natürlich!
October 2021

Synergistic Inhibition of Platelet Activation by Plasmin and Prostaglandin I (2)

Author(s): Zavoico, G., Loscalzo, J., Maas, A.

Journal/Book: Blood. 1987; 69: 1504-1507.

Abstract: Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platelet function. PGI2 and plasmin cause synergistic inhibition of thrombin- and ADP-induced aggregation of washed platelets. Inhibition by PGI2 is similarly potentiated by TPA added to platelet-rich plasma to generate plasmin. Thrombin-stimulated rise in platelet cytosolic Ca2+, measured by fura2 fluorescence, and thromboxane A2 formation, measured by radioimmunoassay (RIA), are likewise synergistically inhibited by PGI2 and plasmin. Plasmin neither increases nor potentiates PGI2-stimulated increases in platelet cyclic AMP. Thus, PGI2 and plasmin cause synergistic inhibition of platelet activation by both cyclic AMP-dependent and independent mechanisms. This interaction between two different endothelium-derived products may play an important role in localizing the hemostatic plug to, a site of vascular injury by preventing further thrombin-mediated accrual of platelets.

Keyword(s): Platelet

Search only the database: 


Zurück | Weiter

© Top Fit Gesund, 1992-2021. Alle Rechte vorbehalten – ImpressumDatenschutzerklärung